Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values-laboratory and clinical utility

被引:11
|
作者
Kahlmeter, Gunnar [1 ,2 ,3 ]
Turnidge, John [4 ,5 ]
机构
[1] European Comm Antimicrobial Susceptibil Testing EU, Vaxjo, Sweden
[2] Swedish Reference Lab Phenotyp Susceptibil Testing, Vaxjo, Sweden
[3] EUCAST Dev Lab, Vaxjo, Sweden
[4] European Comm Antimicrobial Susceptibil Testing EU, Document & Tech Support, Vaxjo, Sweden
[5] Univ Adelaide, Sch Biol Sci, Adelaide, Australia
关键词
ECOFF; epidemiological cut-off value; antimicrobial susceptibility testing; AST; phenotypic wild-type distribution; ECV; MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY; EUCAST; BREAKPOINTS; BACTERIA; ECOFFS;
D O I
10.1128/cmr.00100-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The characterization of wild-type minimum inhibitory concentration (MIC) and zone diameter distributions with the setting of epidemiological cut-off values (ECOFFs or ECVs) provides a reference for the otherwise relative MIC values in the international system for antimicrobial susceptibility testing. Distributions of MIC values for a species and an agent follow a log-normal distribution, which in the absence of resistance mechanisms is monomodal and designated wild type (WT). The upper end of the WT distribution, the ECOFF, can be identified with statistical methods. In the presence of phenotypically detectable resistance, the distribution has at least one more mode (the non-WT), but despite this, the WT is most often identifiable using the same methods. The ECOFF provides the most sensitive measure of resistance development in a species against an agent. The WT and non-WT modes are independent of the organism ' s response to treatment, but when the European Committee on Antimicrobial Susceptibility Testing (EUCAST) determines the clinical breakpoints, the committee avoids breakpoints that split WT distributions of target species. This is to avoid the poorer reproducibility of susceptibility categorization when breakpoints split major populations but also because the EUCAST has failed to identify different clinical outcomes for isolates with different MIC values inside the wild-type distribution. In laboratory practice, the ECOFF is used to screen for and exclude resistance and allows the comparison of resistance between systems with different breakpoints from different breakpoint organizations, breakpoints evolving over time, and different breakpoints between human and animal medicine. The EUCAST actively encourages colleagues to question MIC distributions as presented on the website (https://www.eucast.org/mic_and_zone_distributions_and_ecoffs) and to contribute MIC and inhibition zone diameter data.
引用
收藏
页数:14
相关论文
共 43 条
  • [21] Tentative clinical breakpoints and epidemiological cut-off values of nemonoxacin for Streptococcus pneumoniae and Staphylococcus aureus isolates associated with community-acquired pneumonia
    Jean, Shio-Shin
    Chang, Li-Wen
    Hsueh, Po-Ren
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 23 : 388 - 393
  • [22] Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida Time for harmonization of CLSI and EUCAST broth microdilution methods
    Pfaller, M. A.
    Andes, D.
    Diekema, D. J.
    Espinel-Ingroff, A.
    Sheehan, D.
    DRUG RESISTANCE UPDATES, 2010, 13 (06) : 180 - 195
  • [23] Clinical utility of using lower troponin I cut-off values for point-of-care testing in patients with myocardial infarction in a cardiovascular center
    Arias, R.
    De Luna, A.
    CLINICA CHIMICA ACTA, 2019, 493 : S646 - S647
  • [24] Brain pharmacokinetics of mono- and bispecific amyloid-β antibodies in wild-type and Alzheimer’s disease mice measured by high cut-off microdialysis
    Ulrika Julku
    Mengfei Xiong
    Elin Wik
    Sahar Roshanbin
    Dag Sehlin
    Stina Syvänen
    Fluids and Barriers of the CNS, 19
  • [25] Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution
    Pfaller, M. A.
    Espinel-Ingroff, A.
    Canton, E.
    Castanheira, M.
    Cuenca-Estrella, M.
    Diekema, D. J.
    Fothergill, A.
    Fuller, J.
    Ghannoum, M.
    Jones, R. N.
    Lockhart, S. R.
    Martin-Mazuelos, E.
    Melhem, M. S. C.
    Ostrosky-Zeichner, L.
    Pappas, P.
    Pelaez, T.
    Peman, J.
    Rex, J.
    Szeszs, M. W.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (06) : 2040 - 2046
  • [26] Brain pharmacokinetics of mono- and bispecific amyloid-β antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis
    Julku, Ulrika
    Xiong, Mengfei
    Wik, Elin
    Roshanbin, Sahar
    Sehlin, Dag
    Syvanen, Stina
    FLUIDS AND BARRIERS OF THE CNS, 2022, 19 (01)
  • [27] In vitro activities of current and new antifungal agents against Candida blood isolates according to new CLSI epidemiological cut-off values and clinical breakpoints
    Marcos-Arias, C.
    MYCOSES, 2013, 56 : 61 - 61
  • [28] Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution
    Pfaller, M. A.
    Boyken, L.
    Hollis, R. J.
    Kroeger, J.
    Messer, S. A.
    Tendolkar, S.
    Diekema, D. J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (02) : 630 - 637
  • [29] SUGGESTION OF OPTICAL SPECTRAL TRANSMISSION IMAGING (HANDSCAN) CUT-OFF VALUES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND CORRELATIONS WITH CLINICAL AND LABORATORY DISEASE ACTIVITY MARKERS.
    Triantafyllias, K.
    Altamimi, K.
    De Blasi, M.
    Schwarting, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1034 - 1035
  • [30] Clinical interpretation of prostate-specific antigen values: Type of applied cut-off value exceeds methods bias as the major source of variation
    Klinkenberg, Lieke J. J.
    Lentjes, Eef G. W. M.
    Boer, Arjen-Kars
    ANNALS OF CLINICAL BIOCHEMISTRY, 2019, 56 (02) : 259 - 265